Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Miksicek, R. J.
Right arrow Articles by Leygue, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Miksicek, R. J.
Right arrow Articles by Leygue, E.
[Cancer Research 62, 2736-2740, May 15, 2002]
© 2002 American Association for Cancer Research


Advances in Brief

Identification of a Novel Breast- and Salivary Gland-specific, Mucin-like Gene Strongly Expressed in Normal and Tumor Human Mammary Epithelium1

Richard J. Miksicek2,3, Yvonne Myal2, Peter H. Watson, Christina Walker, Leigh C. Murphy and Etienne Leygue

Department of Physiology, Michigan State University, East Lansing, Michigan 48824 [R. J. M.]; Department of Pathology, University of Manitoba, Winnipeg, Manitoba, R3E 0W3 Canada [Y. M., P. H. W.]; Department of Biochemistry and Medical Genetics and Manitoba Institute of Cell Biology, University of Manitoba, Winnipeg, Manitoba, R3E 0W3 Canada [P. H. W., C. W., L. C. M., E. L.]

Expression profiling using the public expressed sequence tag (EST) and serial analysis of geneexpression (SAGE) databases resulted in the identification of a putativebreast-specific mRNA that we have termed small breast epithelial mucin (SBEM). Hybridization analysis performed on 43 normal human tissues revealed that the SBEM gene was only expressed in mammary and salivary glands. Further reverse-transcription PCR analyses confirmed SBEM expression in most of established human breast epithelial cell lines analyzed (7 of 8) but not in cell lines of non-breast origin (0 of 6). SBEM mRNA expression was detected in >90% of invasive ductal carcinomas and correlated with the expression of a previously characterized breast-specific gene, mammaglobin-1 (n = 54; Spearman r = 0.34, P = 0.011). Interestingly, a higher SBEM:mammaglobin-1 ratio was observed in primary tumors with axillary lymph node metastasis than in node-negative tumors (n = 46; Mann-Whitney, P = 0.04). In a subset of 20 primary breast tumors and their matched axillary lymph nodes, a high concordance (Fisher’s exact test, P < 0.001) was seen between PCR detection of SBEM mRNA in lymph node tissue and their histopathological status, indicating that SBEM mRNA expression is conserved in nodal metastasis. The SBEM gene is predicted to code for a putative low molecular weight, secreted sialoglycoprotein, potentially useful for the diagnosis of metastatic breast cancer.




This article has been cited by other articles:


Home page
Endocr Relat CancerHome page
M. Lacroix
Significance, detection and markers of disseminated breast cancer cells
Endocr. Relat. Cancer, December 1, 2006; 13(4): 1033 - 1067.
[Abstract] [Full Text] [PDF]


Home page
J. Mol. Diagn.Home page
F. Hube, Y. Myal, E. Leygue, J. Rollin, Y. Gruel, Y. Yatabe, and on behalf of the authors
Expression of Two Breast-Specific Molecules in the Lung
J. Mol. Diagn., July 1, 2006; 8(3): 390 - 393.
[Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
L. Radvanyi, D. Singh-Sandhu, S. Gallichan, C. Lovitt, A. Pedyczak, G. Mallo, K. Gish, K. Kwok, W. Hanna, J. Zubovits, et al.
The gene associated with trichorhinophalangeal syndrome in humans is overexpressed in breast cancer
PNAS, August 2, 2005; 102(31): 11005 - 11010.
[Abstract] [Full Text] [PDF]


Home page
J Mol EndocrinolHome page
L C Murphy, B Peng, A Lewis, J R Davie, E Leygue, A Kemp, K Ung, M Vendetti, and R Shiu
Inducible upregulation of oestrogen receptor-{beta}1 affects oestrogen and tamoxifen responsiveness in MCF7 human breast cancer cells
J. Mol. Endocrinol., April 1, 2005; 34(2): 553 - 566.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
M. Mitas, J. S. Almeida, K. Mikhitarian, W. E. Gillanders, D. N. Lewin, D. D. Spyropoulos, L. Hoover, A. Graham, T. Glenn, P. King, et al.
Accurate Discrimination of Barrett's Esophagus and Esophageal Adenocarcinoma Using a Quantitative Three-Tiered Algorithm and Multimarker Real-time Reverse Transcription-PCR
Clin. Cancer Res., March 15, 2005; 11(6): 2205 - 2214.
[Abstract] [Full Text] [PDF]


Home page
J. Mol. Diagn.Home page
T. Koga, Y. Horio, T. Mitsudomi, T. Takahashi, and Y. Yatabe
Identification of MGB1 as a Marker in the Differential Diagnosis of Lung Tumors in Patients with a History of Breast Cancer by Analysis of Publicly Available SAGE Data
J. Mol. Diagn., May 1, 2004; 6(2): 90 - 95.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2002 by the American Association for Cancer Research.